M

Active Director Director DIN 11395217
DIN 11395217 First appointment Nov 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Mehnaz

Data last updated:

Mehnaz is a Director at Zellect Pharmaceuticals Private Limited (since 2026) and Director at Tabtass India Pharmaceuticals Private Limited (since 2025). The companies operate in Pharma.

DIN 11395217
Primary Designation Director
Industry Pharma
First Appointment 25 Nov 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Jan 20262026Active
Director25 Nov 20252025Active

Directorship timeline

Open interactive timeline →
Zellect Pharmaceuticals Private Limited
Tabtass India Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mehnaz

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mehnaz

Mehnaz currently holds 2 directorships: Zellect Pharmaceuticals Private Limited (Director, since 16 Jan 2026); Tabtass India Pharmaceuticals Private Limited (Director, since 25 Nov 2025).

Mehnaz was first appointed on 25 Nov 2025 as Director at Tabtass India Pharmaceuticals Private Limited. The most recent appointment on record is 16 Jan 2026 at Zellect Pharmaceuticals Private Limited.

The current boards of Mehnaz's companies include Mohammed Nahid Ansari (Zellect Pharmaceuticals Private Limited), Mohd Iqbal (Tabtass India Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available